Recro Pharma (REPH) Reports Q2 Loss of $0.83/Share

August 11, 2016 7:15 AM EDT
Get Alerts REPH Hot Sheet
Price: $7.13 -2.73%

Today's EPS Names:
PG, CFG, GE, More
Trade REPH Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Recro Pharma (NASDAQ: REPH) reported Q2 EPS of ($0.83), versus ($0.17) reported last year. Revenue for the quarter came in at $17.3 million, versus $18.7 million reported last year.

For earnings history and earnings-related data on Recro Pharma (REPH) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment